دورية أكاديمية
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
| العنوان: | Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance |
|---|---|
| المؤلفون: | Pyszniak,Maria, Tabarkiewicz,Jacek, Åuszczki,Jarogniew |
| بيانات النشر: | Dove Press |
| سنة النشر: | 2016 |
| المجموعة: | Dove Medical Press |
| مصطلحات موضوعية: | OncoTargets and Therapy |
| الوصف: | Maria Pyszniak,1–3 Jacek Tabarkiewicz,1,2 Jarogniew J Åuszczki4,5 1Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, 2Department of Immunology, Faculty of Medicine, University of Rzeszów, Rzeszów, 3Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warszawa, 4Department of Pathophysiology, Medical University of Lublin, 5Isobolographic Analysis Laboratory, Institute of Agricultural Medicine, Lublin, Poland Abstract: The endocannabinoid system (ECS) comprises cannabinoid receptors (CBs), endogenous cannabinoids, and enzymes responsible for their synthesis, transport, and degradation of (endo)cannabinoids. To date, two CBs, CB1 and CB2, have been characterized; however, orphan G-protein-coupled receptor GPR55 has been suggested to be the third putative CB. Several different types of cancer present abnormal expression of CBs, as well as other components of ECS, and this has been shown to correlate with the clinical outcome. Although most effects of (endo)cannabinoids are mediated through stimulation of classical CBs, they also interact with several molecules, either prosurvival or proapoptotic molecules. It should be noted that the mode of action of exogenous cannabinoids differs significantly from that of endocannabinoid and results from the studies on their activity both in vivo and in vitro could not be easily compared. This review highlights the main signaling pathways involved in the antitumor activity of cannabinoids and the influence of their activation on cancer cell biology. We also discuss changes in the expression pattern of the ECS in various cancer types that have an impact on disease progression and patient survival. A growing amount of experimental data imply possible exploitation of cannabinoids in cancer therapy. Keywords: cannabinoids, cancer, cell signaling, cannabinoid receptor, delta-9-tetrahydrocannabinol |
| نوع الوثيقة: | article in journal/newspaper review |
| وصف الملف: | text/html |
| اللغة: | English |
| العلاقة: | https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-b-peer-reviewed-fulltext-article-OTTTest |
| الإتاحة: | https://doi.org/10.2147/OTT.S106944Test https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-b-peer-reviewed-fulltext-article-OTTTest |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.44D17935 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |